Heterologous ChAdOx1 prime-boosted vaccination schedules are non-inferior to homologous vaccination
1. Heterologous AstraZeneca followed by Pfizer vaccination was noninferior to homologous, two-dose AstraZeneca vaccination with a geometric mean ratio of ...